TipRanks
Go Ultimate55% OFF

Alfred Sandrock Insider Profile

4 Followers

Alfred Sandrock, President & CEO, Director at Voyager Therapeutics, holds 472.55K shares in Voyager Therapeutics (Ticker: VYGR), holds 10.17K shares in Biogen (Ticker: BIIB), holds 0.00 shares in Neurocrine (Ticker: NBIX). Most recently, Alfred Sandrock Sold ― shares of Voyager Therapeutics on Apr 03, 2026 for an estimated value of $44.55K.

Alfred Sandrock's Trading History

VYGR
Voyager Therapeutics
Apr 03, 2026President & CEO, DirectorInformative Sell44.55K$812.78K
BIIB
Biogen
Jun 09, 2021Head of Research & DevelopmentUninformative Sell3.38M$2.58M
NBIX
Neurocrine
―Director―$0.00

You May Also Like

Alfred Sandrock insider profile FAQ

What is the percentage of profitable transactions made by Alfred Sandrock?
The percentage of profitable transactions made by Alfred Sandrock is 78%.
What is the average return per transaction made by Alfred Sandrock?
The average return per transaction made by Alfred Sandrock is 32.20%.
What stocks does Alfred Sandrock hold?
Alfred Sandrock holds: VYGR, BIIB, NBIX stocks.
What was Alfred Sandrock’s latest transaction?
Alfred Sandrock’s latest transaction was an Informative Sell of $44.55K.
What was Alfred Sandrock's most profitable transaction?
Alfred Sandrock’s most profitable transaction was an Informative Sell of VYGR stock on April 3, 2024. The return on the trade was 66.70%.
What is Alfred Sandrock's role in Voyager Therapeutics?
Alfred Sandrock's role in Voyager Therapeutics is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.